CORC

在结果中检索

CORC

浏览/检索结果: 共16条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Treatment outcomes and prognosis of patients with primary and acquired BRAF-mutated non-small cell lung cancer: A multicenter retrospective study 期刊论文
GENES CHROMOSOMES & CANCER, 2022
作者:  Wang, Wenxian;  Gu, Xiaodong;  Si, Jinfei;  Pu, Xingxiang;  Wang, Liping
收藏  |  浏览/下载：31/0  |  提交时间：2022/05/16
Combined mTOR/MEK inhibition prevents proliferation and induces apoptosis in NF2-mutant tumors 期刊论文
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 卷号: 23, 期号: 13
作者:  Shi, W-Y;  Lu, X-Y;  Li, N.;  Mao, F-J;  Yang, X-Y
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
SRC and MEK Co-inhibition Synergistically Enhances the Anti-tumor Effect in Both Non-small-cell Lung Cancer (NSCLC) and Erlotinib-Resistant NSCLC 期刊论文
FRONTIERS IN ONCOLOGY, 2019, 卷号: 9
作者:  Yuan, Man;  Xu, Lin-feng;  Zhang, Juan;  Kong, Si-yuan;  Wu, Man
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05
Zoledronic acid enhances the efficacy of the MEK inhibitor trametinib in KRAS mutant cancers 期刊论文
Cancer Letters, 2019, 卷号: Vol.442, 页码: 202-212
作者:  Xinyu Dai;  Hongwei Xia;  Sheng Zhou;  Qiulin Tang;  Feng Bi
收藏  |  浏览/下载：8/0  |  提交时间：2019/02/28
aberrantmodulationofribosomalproteins6phosphorylationconfersacquiredresistancetomapkpathwayinhibitorsinbrafmutantmelanoma 期刊论文
中国药理学报英文版, 2019, 卷号: 040, 期号: 002, 页码: 268
作者:  Mingzhao Gao;  Hongbin Wang;  Xiangling Chen;  Wenting Cao;  Li Fu
收藏  |  浏览/下载：6/0  |  提交时间：2020/07/01
Aberrant modulation of ribosomal protein S6 phosphorylation confers acquired resistance to MAPK pathway inhibitors in BRAF-mutant melanoma 期刊论文
Acta pharmacologica Sinica, 2018
作者:  Gao, Ming-Zhao;  Wang, Hong-Bin;  Chen, Xiang-Ling;  Cao, Wen-Ting;  Fu, Li
收藏  |  浏览/下载：23/0  |  提交时间：2019/01/08
ERRα suppression enhances the cytotoxicity of the MEK inhibitor trametinib against colon cancer cells 期刊论文
Journal of Experimental & Clinical Cancer Research, 2018, 卷号: Vol.37 No.1, 页码: 1-14
作者:  Sheng Zhou;  Hongwei Xia;  Huanji Xu;  Qiulin Tang;  Yongzhan Nie
收藏  |  浏览/下载：4/0  |  提交时间：2019/02/25
ERRα suppression enhances the cytotoxicity of the MEK inhibitor trametinib against colon cancer cells 期刊论文
Journal of Experimental & Clinical Cancer Research, 2018, 卷号: Vol.37 No.1, 页码: 1-14
作者:  Sheng Zhou;  Hongwei Xia;  Huanji Xu;  Qiulin Tang;  Yongzhan Nie
收藏  |  浏览/下载：8/0  |  提交时间：2019/02/25
Acute Myeloid Leukaemia Therapy Relevant Drug-Drug Interaction (DDI) Due to the Pharmacokinetic Factors 期刊论文
LATIN AMERICAN JOURNAL OF PHARMACY, 2018, 卷号: 37, 期号: 4, 页码: 804-807
作者:  Ji, Mu-Yuan;  Yang, Xiao-Mei;  Wei, Ruo-Ying;  Zhang, Yuan-Yuan;  Liu, Zhi-Juan
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/11
AKT is critically involved in the antagonism of BRAF inhibitor sorafenib against dabrafenib in colorectal cancer cells harboring both wild-type and mutant (V600E) BRAF genes 期刊论文
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 卷号: 489, 期号: 1, 页码: 14-20
作者:  Wang, Hongbin;  Quan, Haitian;  Lou, Liguang
收藏  |  浏览/下载：24/0  |  提交时间：2019/01/08

©版权所有 ©2017 CSpace - Powered by CSpace